Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Paula GREEN |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Maternal depression and infant cortisol: influences of timing, comorbidity and treatment / Patricia A. BRENNAN in Journal of Child Psychology and Psychiatry, 49-10 (October 2008)
[article]
Titre : Maternal depression and infant cortisol: influences of timing, comorbidity and treatment Type de document : Texte imprimé et/ou numérique Auteurs : Patricia A. BRENNAN, Auteur ; Rebecca PARGAS, Auteur ; Elaine F. WALKER, Auteur ; Paula GREEN, Auteur ; D. Jeffrey NEWPORT, Auteur ; Zachary STOWE, Auteur Année de publication : 2008 Article en page(s) : p.1099-1107 Langues : Anglais (eng) Mots-clés : Anxiety cortisol depression infant perinatal prenatal psychotropic stress Index. décimale : PER Périodiques Résumé : Background: The current study examines the relationship between maternal depression and infant cortisol concentrations. The potential roles of comorbid maternal anxiety disorders, timing of maternal depression, and maternal treatment with psychotropic medications during pregnancy are addressed.
Methods: Women with 6-month-old infants (105 boys and 84 girls) participated in a laboratory paradigm that included infant saliva collection at six points, noise burst and arm restraint stressor tasks, and a diagnostic interview of the mother.
Results: Lifetime history of maternal depression was associated with increased baseline and mean (average) infant cortisol levels. Comorbidity with anxiety disorder was related to infant cortisol reactivity. Peripartum (prepartum and/or postpartum) maternal depression, rather than a pre-pregnancy history of disorder, was associated with higher infant cortisol reactivity. Prenatal and postnatal exposure to maternal disorder had similar effects, but prenatal maternal psychotropic medication treatment appeared to attenuate infant cortisol increases associated with prenatal maternal disorder exposure.
Conclusions: These data suggest that exposure to maternal depression and anxiety during pregnancy and the postpartum period may increase infant salivary cortisol. This maternal depression–infant cortisol association is independent of the effects of delivery complications, and appears to be modulated by prenatal maternal psychotropic treatment.En ligne : http://dx.doi.org/10.1111/j.1469-7610.2008.01914.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=607
in Journal of Child Psychology and Psychiatry > 49-10 (October 2008) . - p.1099-1107[article] Maternal depression and infant cortisol: influences of timing, comorbidity and treatment [Texte imprimé et/ou numérique] / Patricia A. BRENNAN, Auteur ; Rebecca PARGAS, Auteur ; Elaine F. WALKER, Auteur ; Paula GREEN, Auteur ; D. Jeffrey NEWPORT, Auteur ; Zachary STOWE, Auteur . - 2008 . - p.1099-1107.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 49-10 (October 2008) . - p.1099-1107
Mots-clés : Anxiety cortisol depression infant perinatal prenatal psychotropic stress Index. décimale : PER Périodiques Résumé : Background: The current study examines the relationship between maternal depression and infant cortisol concentrations. The potential roles of comorbid maternal anxiety disorders, timing of maternal depression, and maternal treatment with psychotropic medications during pregnancy are addressed.
Methods: Women with 6-month-old infants (105 boys and 84 girls) participated in a laboratory paradigm that included infant saliva collection at six points, noise burst and arm restraint stressor tasks, and a diagnostic interview of the mother.
Results: Lifetime history of maternal depression was associated with increased baseline and mean (average) infant cortisol levels. Comorbidity with anxiety disorder was related to infant cortisol reactivity. Peripartum (prepartum and/or postpartum) maternal depression, rather than a pre-pregnancy history of disorder, was associated with higher infant cortisol reactivity. Prenatal and postnatal exposure to maternal disorder had similar effects, but prenatal maternal psychotropic medication treatment appeared to attenuate infant cortisol increases associated with prenatal maternal disorder exposure.
Conclusions: These data suggest that exposure to maternal depression and anxiety during pregnancy and the postpartum period may increase infant salivary cortisol. This maternal depression–infant cortisol association is independent of the effects of delivery complications, and appears to be modulated by prenatal maternal psychotropic treatment.En ligne : http://dx.doi.org/10.1111/j.1469-7610.2008.01914.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=607